Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Post Hematopoietic Stem Cell Transplant”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00436618
What this trial is testing

Everolimus in Treating Patients With Lymphoma That Has Relapsed or Not Responded to Previous Treatment

Who this might be right for
LeukemiaLymphomaLymphoproliferative Disorder
Mayo Clinic 277
Post-approval studies (Phase 4)Study completedNCT01610297
What this trial is testing

Post Hematopoietic Stem Cell Transplantation

Who this might be right for
Iron Overload After Hematopoietic Stem Cell Transplantation (HSCT) in Patients With Beta-thalassemia Major
Novartis Pharmaceuticals 27
Not applicableLooking for participantsNCT04745221
What this trial is testing

Efficacy and Safety of Auto-FMT in Preventing aGVHD

Who this might be right for
Graft Versus Host Disease, Acute
The First Affiliated Hospital of Soochow University 100
Testing effectiveness (Phase 2)Study completedNCT00792142
What this trial is testing

Bortezomib, Thalidomide, and Dexamethasone After Melphalan and Stem Cell Transplant in Treating Patients With Stage I-III Multiple Myeloma

Who this might be right for
Multiple Myeloma and Plasma Cell NeoplasmNeurotoxicity
City of Hope Medical Center 45
Testing effectiveness (Phase 2)WithdrawnNCT05509582
What this trial is testing

Extension Study (Extended Access) of Syk-inhibition Using Fostamatinib to Treat Posttransplant Immune-mediated Cytopenias

Who this might be right for
Immune Mediated AnemiaImmune Mediated ThrombocytopeniaChronic GVHD
National Heart, Lung, and Blood Institute (NHLBI)
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07449286
What this trial is testing

IFN-α in Relapse Prevention.

Who this might be right for
Acute Myeloid LeukemiaMyelodysplastic Syndromes
Peking University People's Hospital 100
Early research (Phase 1)Study completedNCT03340766
What this trial is testing

Study Investigating the Safety and Efficacy of Blinatumomab in Combination With Pembrolizumab in Adults With Relapsed or Refractory Diffuse Large B Cell Lymphoma (DLBCL)

Who this might be right for
Relapsed or Refractory Diffuse Large B Cell Lymphoma (DLBCL)
Amgen 31
Not applicableWithdrawnNCT02052570
What this trial is testing

School Reintegration After Pediatric Hematopoietic Stem Cell Transplant

Who this might be right for
Unspecified Complication of Bone Marrow Transplant
Duke University
Large-scale testing (Phase 3)Not Yet RecruitingNCT07686965
What this trial is testing

Lisaftoclax Plus Azacitidine Maintenance After Allogeneic Hematopoietic Stem Cell Transplantation in Acute Myeloid Leukemia Patients at High Risk of Relapse

Who this might be right for
Acute Myeloid Leukemia (AML)Maintenance TreatmentHematopoetic Stem Cell Transplantation
Institute of Hematology & Blood Diseases Hospital, China 191
Testing effectiveness (Phase 2)WithdrawnNCT03515707
What this trial is testing

Stem Cell Transplant to Treat Patients With Favorable or Intermediate Risk Minimal Residual Disease Negative Acute Myeloid Leukemia

Who this might be right for
Acute Myeloid LeukemiaMinimal Residual Disease Negativity
Fred Hutchinson Cancer Center
Large-scale testing (Phase 3)Looking for participantsNCT06918002
What this trial is testing

Elranatamab/Lenalidomide Consolidation and/or Elranatamab Maintenance Versus Standard of Care After D-VRd Induction in Transplant-eligible NDMM Patients

Who this might be right for
Multiple Myeloma, Newly Diagnosed
Intergroupe Francophone du Myelome 824
Testing effectiveness (Phase 2)UnknownNCT02083731
What this trial is testing

MSC for Treatment of CMV Infection

Who this might be right for
Stem Cell Transplantation, HematopoieticCMV InfectionHematological Diseases
Nanfang Hospital, Southern Medical University 120
Not applicableStudy completedNCT01061801
What this trial is testing

Spouses/Partners Expressing Their Thoughts After Transplant

Who this might be right for
CancerHematopoietic Stem Cell Transplantation
Fred Hutchinson Cancer Center 122
Testing effectiveness (Phase 2)Study completedNCT00968630
What this trial is testing

Immune Response After Stem Cell Transplant in HIV-Positive Patients With Hematologic Cancer

Who this might be right for
Hematopoietic and Lymphoid Cell NeoplasmHIV Infection
Fred Hutchinson Cancer Center 9
Testing effectiveness (Phase 2)Study completedNCT02210065
What this trial is testing

Autologous Cytomegalovirus (CMV)-Specific Cytotoxic T Cells for Cytomegalovirus (CMV) Reactivation

Who this might be right for
LeukemiaLymphoma
M.D. Anderson Cancer Center 6
Testing effectiveness (Phase 2)Looking for participantsNCT06299462
What this trial is testing

PTCy and ATG for MSD and MUD Transplants

Who this might be right for
Acute Myeloid LeukemiaAcute Lymphoblastic LeukemiaMyelodysplastic Syndromes+2 more
Instituto Nacional de Cancer, Brazil 50
Large-scale testing (Phase 3)Study completedNCT00049673
What this trial is testing

Thalidomide and Prednisone After Autologous Stem Cell Transplantation Multiple Myeloma

Who this might be right for
Multiple Myeloma and Plasma Cell Neoplasm
NCIC Clinical Trials Group 332
Early research (Phase 1)Study completedNCT02313857
What this trial is testing

Most Closely Human Leukocyte Antigen (HLA)-Matched CMV-specific T Lymphocytes (Viralym-C)

Who this might be right for
CMV Infections
AlloVir 10
Not applicableUnknownNCT04336501
What this trial is testing

Efficacy and Safety Evaluation of IM19 CAR-T Cell Therapy for MRD+ After Transplantation

Who this might be right for
Leukemia
Beijing Immunochina Medical Science & Technology Co., Ltd. 20
Large-scale testing (Phase 3)Looking for participantsNCT07389616
What this trial is testing

A Clinical Trial of Cidabenamine Plus Azacitidine to Prevent Post-Transplant Progression in High-Risk Peripheral T-Cell Lymphoma

Who this might be right for
Peripheral T Cell Lymphoma
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine 40
Next Page